<?xml version="1.0" encoding="UTF-8"?>
<p id="p0080">Ensuring the supply of medical products remains essential, especially in emergency health situations, when the risk for shortages can be elevated. Simplified and exceptional management of regulatory processes have therefore been adopted by various regulators to maintain supply and to lower the risk for such shortages. These processes have complemented industry efforts, such as increasing production and donating medical products where needed. Expedited reviews have been offered (
 <xref rid="tbl1" ref-type="table">TableÂ I</xref>) and have been useful, especially for post-approval changes, such as in the case of the European Union's use of the exceptional change management process.
 <xref rid="bib27" ref-type="bibr">
  <sup>27</sup>
 </xref> With regard to ensuring good practices, regulators have offered to conduct inspections remotely
 <xref rid="bib28" ref-type="bibr">
  <sup>28</sup>
 </xref> or have granted sponsors existing marketing-authorization approval extensions, automatic recertifications, or temporary certifications.
 <xref rid="bib27" ref-type="bibr">
  <sup>27</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib29" ref-type="bibr">
  <sup>29</sup>
 </xref>
</p>
